Beste Retinoblastom pädiatrische Onkologen in der Türkei - TOP -16 Ärzte

• Dr. Yesim Yildirim ist auf die Behandlung von Retinoblastomen spezialisiert.
• Zu den Behandlungen gehören Chemotherapie, Strahlentherapie und Lasertherapie.
• Internationale Praxis in den Vereinigten Staaten, der Türkei, Israel und Großbritannien.
• Verfügt über die ESMO-Zertifizierung und gewährleistet so erstklassige onkologische Fachkompetenz.
• Mitglied der ESMO und der European School of Oncology (ESO).
• Bietet Online-Konsultationen für Retinoblastom-Patienten weltweit an.
• Spricht Englisch, Türkisch und Russisch (Niveau B1).

Experience

2021 - 2022

Clinical Manager of Radiation Oncology, Medicana International Istanbul Hospital

2021 - 2022

Department of Radiation Oncology, Biruni University Faculty of Medicine

2020 - 2021

Clinical Manager of Radiation Oncology, Medicana International Istanbul Hospital

2017 - 2020

Clinical Manager of Radiation Oncology, Neolife Medical Center

2016 - 2017

Department of Radiation Oncology, Eskişehir Osmangazi University Faculty of Medicine

2011 - 2016

Department of Radiation Oncology, Eskişehir Osmangazi University Faculty of Medicine

2010 - 2011

Department of Radiation Oncology, Eskişehir Osmangazi University Faculty of Medicine

2008 - 2010

Radiation Oncology Clinic, Samsun Training and Research Hospital (Education Coordinator)

2006

Medical Faculty, Dokuz Eylül University

2006 - 2008

Radiation Oncology Clinic, Samsun Mehmet Aydın State Hospital (Compulsory Service)

2000 - 2006

Medical Faculty, Dokuz Eylül University

Education

2022

Biruni University Faculty of Medicine, Department of Radiation Oncology, Faculty Member, Professor Doctor

2022

Anadolu University Open Education Faculty Undergraduate Program, Cultural Heritage and Tourism

2021

Feyziye Schools Foundation Işık University Health Services Vocational School, Faculty Member, Associate Professor Doctor

2017

Eskişehir Osmangazi University Faculty of Medicine, Department of Radiation Oncology, Faculty Member

2017

Eskişehir Osmangazi University Faculty of Medicine, Department of Radiation Oncology, Associate Professor Doctor

2006

Samsun Training and Research Hospital, Specialist Doctor, Compulsory Service

2006

Dokuz Eylül University Faculty of Medicine, Department of Radiation Oncology, Medical Specialization

1998

Ege University, Faculty of Medicine

• Dr. Alp Özkan ist auf fortgeschrittene Retinoblastom-Behandlungen spezialisiert.
• Zu den Behandlungsmethoden gehören Operationen, Chemotherapie, Strahlentherapie und Kryotherapie.
• Internationale Praxis in den Vereinigten Staaten zur Verbesserung des Fachwissens in der Retinoblastom-Behandlung.
• Leiter der pädiatrischen Onkologie am Anadolu Medical Center mit Schwerpunkt auf Krebserkrankungen bei Kindern.
• Akkreditierter Onkologe mit umfassender Erfahrung in pädiatrischen Malignomen.
• Beteiligt sich an Fernkonsultationen für Patienten mit Retinoblastom.
• Fließende Englisch- und Türkischkenntnisse ermöglichen eine umfassende Patientenkommunikation.

• Spezialisiert auf fortgeschrittene Behandlungsoptionen für Retinoblastome.
• Zu den Behandlungsmethoden gehören Chemotherapie, Strahlentherapie und Lasertherapie.
• Internationale Praxis in Europa, den USA und Asien.
• Anerkannter Experte für pädiatrische ophthalmologische Onkologie.
• Vom Facharzt für Augenheilkunde zertifiziert, was erstklassige Pflege und Fachwissen gewährleistet.
• Aktives Mitglied führender Gesellschaften für Augenheilkunde und Onkologie.
• Bietet Online-Konsultationen für Patienten mit Retinoblastom weltweit an.
• Beratungen auf Englisch und Türkisch, um den Zugang für Patienten zu verbessern.

Sema Yılmaz was born on July 30, 1965. She received her undergraduate degree from Istanbul University Cerrahpaşa Medical Faculty and completed her medical residency training at the Department of Pediatrics at Zeynep Kamil Women's and Children's Health and Diseases Hospital. She also completed her medical subspecialty training in Pediatric Hematology/Oncology at Cukurova University. Her medical residency thesis was titled "The Relationship Between Morning First Urine Density and Nocturnal Enuresis in Children Aged 3-6 Years", and her medical subspecialty thesis was titled "Comparison of Sphingosine 1-phosphate Receptor 4 Gene Expression in Healthy Children and Neuroblastoma Patients". She started her medical career as a general practitioner. After working as a general practitioner for 4 years, she worked as a doctor researcher at Zeynep Kamil Women's and Children's Health and Diseases Training and Research Hospital for 5 years. She then served as a specialist doctor, assistant professor, and associate professor at various institutions. She worked at Houston MD Anderson, North Carolina-UNC, Boston-Harvard University in the USA. Additionally, she conducted research on cell therapies. She received the title of professor in Pediatric Hematology/Oncology at Usak Medical Faculty. She is a member of the Turkish Pediatric Oncology Group, European Association for Cancer Research (EACR), Turkish Medical Association, Turkish National Pediatrics Association, Turkish Pediatrics Association, Pediatrics Specialty Academy Association (PUADER), Turkish Immunology Association, Turkish Hematology Association, and Molecular Oncology Association (MOKAD). She currently serves her patients at Koru Hospital. Her medical interests include:

Cell therapies in childhood cancers

Cancer immunology

Investigation of genetic pathways responsible for cancer and metastasis

Pulmonary microbiota

BAL transplantation